Abstract:Icariin, a flavonoid glycoside, is extracted from Epimedium. This study aimed to investigate the vascular protective effects of icariin in type 1 diabetic rats by inhibiting high-mobility group box 1 (HMGB1)-related inflammation and exploring its potential mechanisms. The impact of icariin on vascular dysfunction was assessed in streptozotocin (STZ)-induced diabetic rats through vascular reactivity studies. Western blotting and immunofluorescence assays were performed to measure the expressions of target proteins. The release of HMGB1 and pro-inflammation cytokines were measured by enzyme-linked immunosorbent assay (ELISA). The results revealed that icariin administration enhanced acetylcholine-induced vasodilation in the aortas of diabetic rats. It also notably reduced the release of pro-inflammatory cytokines, including interleukin-8 (IL-8), IL-6, IL-1β, and tumor necrosis factor-alpha (TNF-α) in diabetic rats and high glucose (HG)-induced human umbilical vein endothelial cells (HUVECs). The results also unveiled that the pro-inflammatory cytokines in the culture medium of HUVECs could be increased by rHMGB1. The increased release of HMGB1 and upregulated expressions of HMGB1-related inflammatory factors, including advanced glycation end products (RAGE), Toll-like receptor 4 (TLR4), and phosphorylated p65 (p-p65) in diabetic rats and HG-induced HUVECs, were remarkably suppressed by icariin. Notably, HMGB1 translocation from the nucleus to the cytoplasm in HUVECs under HG was inhibited by icariin. Meanwhile, icariin could activate G protein-coupled estrogen receptor (GPER) and sirt1. To explore the role of GPER and Sirt1 in the inhibitory effect of icariin on HMGB1 release and HMGB-induced inflammation, GPER inhibitor and Sirt1 inhibitor were used in this study. These inhibitors diminished the effects of icariin on HMGB1 release and HMGB1-induced inflammation. Specifically, the GPER inhibitor also negated the activation of Sirt1 by icariin. These findings suggest that icariin activates GPER and increases the expression of Sirt1, which in turn reduces HMGB1 translocation and release, thereby improving vascular endothelial function in type 1 diabetic rats by inhibiting inflammation.

Icariin Attenuates Angiotensin II-induced Hypertrophy and Apoptosis in H9c2 Cardiomyocytes by Inhibiting Reactive Oxygen Species-Dependent JNK and P38 Pathways.

Icariin Protects H9c2 Cardiomyocytes from Lipopolysaccharide-Induced Injury Via Inhibition of the Reactive Oxygen Species-Dependent C-Jun N-terminal Kinases/nuclear Factor-Κb Pathway

Icariin Promotes Expression of Junctophilin 2 and Ca2+ Related Function During Cardiomyocyte Differentiation of Murine Embryonic Stem Cells.

Icariin inhibits isoproterenol-induced cardiomyocyte hypertropic injury through activating autophagy via the AMPK/mTOR signaling pathway

Involvement of p38MAPK and reactive oxygen species in icariin-induced cardiomyocyte differentiation of murine embryonic stem cells in vitro.

Icariin-mediated Expression of Cardiac Genes and Modulation of Nitric Oxide Signaling Pathway During Differentiation of Mouse Embryonic Stem Cells into Cardiomyocytes in Vitro.

Icariin Promotes Expression of PGC-1α, PPARα, and NRF-1 During Cardiomyocyte Differentiation of Murine Embryonic Stem Cells in Vitro

Icariin-Mediated Modulation of Cell Cycle and P53 During Cardiomyocyte Differentiation in Embryonic Stem Cells

Epigallocatechin-3-gallate inhibits angiotensin II-induced cardiomyocyte hypertrophy via regulating Hippo signaling pathway in H9c2 rat cardiomyocytes.

Icariin Attenuates Vascular Endothelial Dysfunction by Inhibiting Inflammation Through GPER/Sirt1/HMGB1 Signaling Pathway in Type 1 Diabetic Rats

Icariside II attenuates cardiac remodeling via AMPKα2/mTORC1 in vivo and in vitro.

Inhibition of Histone Demethylase JMJD1C Attenuates Cardiac Hypertrophy and Fibrosis Induced by Angiotensin II

Bioactive molecule Icariin inhibited proliferation while enhanced apoptosis and autophagy of rat airway smooth muscle cells in vitro

ICSII Attenuates Cardiomyocyte Apoptosis in Spontaneously Hypertensive Rats by Inhibiting Oxidative Stress, Mitochondrial Apoptosis Signaling Pathway and Endoplasmic Reticulum Stress of Their Myocardial Cells

Icariin Ameliorates Diabetic Cardiomyopathy Through Apelin/Sirt3 Signalling to Improve Mitochondrial Dysfunction

Angiotensin II prompts heart cell apoptosis via AT1 receptor-augmented phosphatase and tensin homolog and miR-320-3p functions to enhance suppression of the IGF1R-PI3K-AKT survival pathway

Icariin promotes angiogenic differentiation and prevents oxidative stress-induced autophagy in endothelial progenitor cells.

Nardosinone Protects H9c2 Cardiac Cells from Angiotensin Ii-Induced Hypertrophy

Irisin Ameliorates Angiotensin II‐induced Cardiomyocyte Apoptosis Through Autophagy

Icarrin prevents cardiomyocyte apoptosis in spontaneously hypertensive rats by inhibiting endoplasmic reticulum stress pathways

Icariin Attenuates Diabetic Cardiomyopathy and Downregulates Extracellular Matrix Proteins in Heart Tissue of Type 2 Diabetic Rats.